< Back to previous page
Researcher
Johan Maertens
- Disciplines:Biochemistry and metabolism, Microbiology, Systems biology, Laboratory medicine, Medical biochemistry and metabolism
Affiliations
- Laboratory of Clinical Bacteriology and Mycology (Division)
Member
From1 Oct 2014 → Today
Projects
1 - 8 of 8
- Improving prevention and treatment strategies concerning opportunistic infections in immunocompromised hematologic patientsFrom14 Sep 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Clonal evolution and biology of co-operative oncogenic events in acute lymphoblastic leukemia.From1 Oct 2018 → TodayFunding: BOF - Concerted Research Project from 1994
- Fast diagnosis of opportunistic respiratory infections trough exhaled breath analysisFrom1 Oct 2017 → 30 Sep 2020Funding: FWO Applied Biomedical Research (TBM)
- Triazole-resistance in Aspergillus fumigatus: evolving epidemiology and influence on disease progression.From15 Mar 2017 → 2 Dec 2021Funding: BOF - Doctoral projects, BOF - doctoral mandates
- Faster to the fungus: rapid diagnostic and prognostic tests for invasive fungal diseasesFrom1 Aug 2016 → 9 Oct 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Rethinking 'Care after Cure' in allogeneic hematopoietic stem cell transplantation using e-Health and patient reported outcomesFrom1 Sep 2015 → 14 Nov 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Assessment of the impact of emerging azole resistance mechanisms on treatment response of invasive pulmonary aspergillosis using non-invasive imaging in experimental Aspergillus infection models.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project
- Invasive pulmonary aspergillosis: biomarkers in exhaled breath condensate for early diagnosis and diversity of pathogens involved.From1 Oct 2010 → 20 Nov 2015Funding: FWO fellowships, BOF - Doctoral projects
Publications
1 - 10 of 433
- Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study.(2022)
Authors: Joost Wauters, Johan Maertens, Simon Feys, Katrien Lagrou
Pages: e0229821 - Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) (Apr, 10.1038/s41375-022-01556-7, 2022)(2022)
Authors: Johan Maertens
Pages: 1450 - 1450Number of pages: 1 - Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.(2022)
Authors: Johan Maertens
Pages: 2347 - 2354 - COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.(2022)
Authors: Johan Maertens
Pages: 2427 - 2433 - Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)(2022)
Authors: Johan Maertens
Pages: 1215 - 1226Number of pages: 12 - Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing(2022)
Authors: Sarah Meyers, Jolien De Bie, Lucienne Michaux, Nancy Boeckx, Anne Uyttebroeck, Kim De Keersmaecker, Johan Maertens, Heidi Segers, Jan Cools, Sofie Demeyer
Number of pages: 11 - Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping(2022)
Authors: Jolien De Bie, Sofie Demeyer, Jan Cools, Kim De Keersmaecker, Joris Vermeesch, Johan Maertens, Heidi Segers, Lucienne Michaux, Barbara Dewaele
Pages: 548 - 561Number of pages: 14 - Toxoplasmosis after allogeneic haematopoietic cell transplantation: experience using a PCR-guided pre-emptive approach.(2022)
Authors: Toine Mercier, Mariëlle Beckers, Hélène Schoemans, Katrien Lagrou, Johan Maertens
Pages: 440 - 445 - Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial(2022)
Authors: Johan Maertens
Pages: 1115 - 1125Number of pages: 11 - Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT(2022)
Authors: Johan Maertens
Pages: 416 - 422Number of pages: 7